UPDATE 2-FDA panel recommends Sage's postpartum depression treatment
November 02, 2018 at 16:53 PM EDT
An advisory panel to the U.S. Food and Drug Administration on Friday recommended Sage Therapeutics Inc's experimental treatment for postpartum depression, saying the benefits of the drug outweighed risks.
